A new study shows the failure rate for drugs recently developed to treat Alzheimer’s disease was a woeful 99.6 percent, with “disturbingly few new drugs in the pipeline.” The disease is expected to leave millions of baby boomers with dementia in the next few decades.
Subscribe to Alzheimers RSS feed
The Henderson City Council is set to hold a public hearing at its Tuesday meeting to discuss a proposed assisted group living facility in a rural southeast neighborhood.
Jacob Sobotka speaks slowly, painfully. He remembers when he first started struggling for words: November 2011. But when asked his age, he can still crack a joke.
With the rapid rise of the prevalence of Alzheimer’s disease, the important work done inside the Cleveland Clinic Lou Ruvo Center for Brain Health is helping to identify and develop new disease modifying therapies urgently needed to combat this mind-robbing disease. As a leading Alzheimer’s disease clinical trial program, Lou Ruvo Center for Brain Health has a “multiple shots on goal” philosophy, testing many drugs to identify those few that may have beneficial clinical effects.